Left ventricular mass in dippers and nondippers with newly diagnosed hypertension

Paolo Cicconetti1, Sergio Morelli, Caterina De Serra

  • 1Department of Geriatrics, Ist Institute of Medicine, La Sapienza University, Rome, Italy. paolocicconetti@tin.it

Angiology
|December 12, 2003
PubMed

Insights

Hypertension's dipping and nondipping patterns show no difference in early cardiac damage. This study found no increased left ventricular remodeling or hypertrophy in nondippers with newly diagnosed hypertension.

Area of Science:

  • Cardiology
  • Hypertension Research

Background:

  • Hypertension is classified into dipper and nondipper groups based on nocturnal blood pressure fall.
  • Previous studies on cardiac damage in these groups yielded conflicting results due to varied patient cohorts.
  • Early cardiac organ damage in hypertension requires further investigation.

Purpose of the Study:

  • To compare cardiac involvement between dipper and nondipper hypertensive individuals in early disease stages.
  • To investigate differences in left ventricular dimensions, mass, and remodeling between dippers and nondippers.

Main Methods:

  • Selected 23 dippers and 17 nondippers with newly diagnosed ( < 1 year) grades 1-2 hypertension, treatment-naïve.
  • Utilized 24-hour ambulatory blood pressure monitoring and M-mode echocardiography.
  • Assessed echocardiographic parameters including left ventricular and atrial dimensions, left ventricular mass, and relative wall thickness.

Main Results:

  • No significant differences were observed between dippers and nondippers in left ventricular and atrial dimensions.
  • Left ventricular mass, left ventricular mass index, and relative wall thickness showed no significant variations between the groups.
  • The rates of left ventricular remodeling and hypertrophy were comparable in both dipper and nondipper groups.

Conclusions:

  • Nondipping status is not associated with increased cardiac involvement in the early stages of hypertension.
  • Early-stage hypertension management may not require differentiation based on dipping status for cardiac risk assessment.
  • Further research is needed to understand long-term implications of nondipping status on cardiovascular health.

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Hypertension I: Introduction01:28

Hypertension I: Introduction

Hypertension is a widespread, long-term medical condition where blood pressure in the arteries remains elevated. It is characterized by systolic blood pressure readings of 130 mm Hg or above or diastolic blood pressure (DBP) readings of 80 mm Hg or higher. Unmanaged hypertension poses significant health risks, making the distinction between primary (or essential) hypertension and secondary hypertension crucial, as their management and implications vary.Primary HypertensionPrimary hypertension,...
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...